← All Sponsors
SPONSOR

Rutgers, The State University of New Jersey

Total Trials
19
Recruiting
19
Phases
Phase 1, Phase 2, Phase 2, Phase 3, Phase 3, EARLY_Phase 1

Rutgers, The State University of New Jersey is a clinical research sponsor with 19 registered studies on ClinicalTrials.gov, of which 19 are actively recruiting participants. Research covers conditions including Aggression, Self-injurious Behavior, Problem Behavior, Self Injury.

The trial portfolio spans Phase 1, Phase 2, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Rutgers, The State University of New Jersey

How many clinical trials has Rutgers, The State University of New Jersey sponsored?
ClinicalMetric currently tracks 19 clinical trials sponsored by Rutgers, The State University of New Jersey, of which 19 are actively recruiting participants. These trials cover conditions including Aggression, Self-injurious Behavior, Problem Behavior. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Rutgers, The State University of New Jersey research focus on?
Rutgers, The State University of New Jersey clinical trials span Aggression, Self-injurious Behavior, Problem Behavior, Self Injury, Tobacco Use Disorder, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Rutgers, The State University of New Jersey clinical trial?
To participate in a Rutgers, The State University of New Jersey trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Rutgers, The State University of New Jersey trials with current recruitment status updated daily.

Clinical Trials by Rutgers, The State University of New Jersey

NCT04045600
Recruiting

Refinements of Functional Communication Training

Aggression
NCT05925101
Recruiting

Basic and Applied Research on Extinction Bursts

Problem Behavior
NCT07812753
Recruiting

Modulating Neural Mechanisms of Reward Processing in Tobacco Users

Tobacco Use Disorder
NCT06642181 Phase 1
Recruiting

Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Maintenance in Opioid Use Disorder

Mindfulness
NCT06073626
Recruiting

Addressing Genomic Disparities in Cancer Survivors

Hereditary Cancer
NCT06546085
Recruiting

Extracellular Vesicles, Insulin Action, and Exercise

Type 2 Diabetes
NCT05559164 Phase 2
Recruiting

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Cardiac Toxicity
NCT07675499 Phase 2, Phase 3
Recruiting

Exercise and Intranasal Insulin in Type 2 Diabetes

Type 2 Diabetes
NCT06968832
Recruiting

Project COMET: Massed Prolonged Exposure for PTSD and SUD

Posttraumatic Stress Disorder (PTSD)
NCT06336590
Recruiting

Student Exercise and Sleep Timing Study - Part 2

Sleep
NCT05084196 Phase 3
Recruiting

Melatonin for Prevention of Kidney Injury

Acute Kidney Injury
NCT06663813
Recruiting

Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients

Type 2 Diabetes
NCT07060495 Phase 3
Recruiting

RADA16 for Adult Tonsillectomy

Postoperative Pain
NCT02688517
Recruiting

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

Malignant Neoplasm
NCT06797219
Recruiting

Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4

Intraventricular Hemorrhage of Prematurity
NCT06072963 Phase 2
Recruiting

COMMETS- Combination MCI Metabolic Syndrome

Alzheimer Disease
NCT07643012
Recruiting

Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer

Endometrial Cancer
NCT04211259 EARLY_Phase 1
Recruiting

Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization

Plasma Cell Myeloma
NCT05766280
Recruiting

Internet Assisted Career-Oriented Soft-skills Training for Transition Age Youth with Mental Health Conditions

Mental Health Wellness 1
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology